company background image
IQVH logo

IQVIA Holdings WBAG:IQVH Stock Report

Last Price

€214.10

Market Cap

€38.8b

7D

10.0%

1Y

6.0%

Updated

17 Jul, 2024

Data

Company Financials +

IQVH Stock Overview

Engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific.

IQVH fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance4/6
Financial Health1/6
Dividends0/6

IQVIA Holdings Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IQVIA Holdings
Historical stock prices
Current Share PriceUS$214.10
52 Week HighUS$238.00
52 Week LowUS$166.20
Beta1.5
11 Month Change7.86%
3 Month Change-0.51%
1 Year Change5.99%
33 Year Change3.88%
5 Year Changen/a
Change since IPO60.98%

Recent News & Updates

Recent updates

Shareholder Returns

IQVHAT Life SciencesAT Market
7D10.0%2.8%0.1%
1Y6.0%-12.8%9.7%

Return vs Industry: IQVH exceeded the Austrian Life Sciences industry which returned -12% over the past year.

Return vs Market: IQVH underperformed the Austrian Market which returned 10.4% over the past year.

Price Volatility

Is IQVH's price volatile compared to industry and market?
IQVH volatility
IQVH Average Weekly Movement3.2%
Life Sciences Industry Average Movement6.5%
Market Average Movement3.4%
10% most volatile stocks in AT Market6.4%
10% least volatile stocks in AT Market2.0%

Stable Share Price: IQVH has not had significant price volatility in the past 3 months.

Volatility Over Time: IQVH's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a87,000Ari Bousbibwww.iqvia.com

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

IQVIA Holdings Inc. Fundamentals Summary

How do IQVIA Holdings's earnings and revenue compare to its market cap?
IQVH fundamental statistics
Market cap€38.81b
Earnings (TTM)€1.24b
Revenue (TTM)€13.78b

30.9x

P/E Ratio

2.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IQVH income statement (TTM)
RevenueUS$15.07b
Cost of RevenueUS$9.79b
Gross ProfitUS$5.28b
Other ExpensesUS$3.92b
EarningsUS$1.36b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 22, 2024

Earnings per share (EPS)7.45
Gross Margin35.03%
Net Profit Margin9.01%
Debt/Equity Ratio213.6%

How did IQVH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.